Detalhe da pesquisa
1.
Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.
Cell
; 163(5): 1095-1107, 2015 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26553503
2.
Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection.
J Virol
; 90(24): 11122-11131, 2016 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27707930
3.
Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1.
J Virol
; 90(10): 5090-5097, 2016 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26962223
4.
Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site.
J Virol
; 90(2): 780-9, 2016 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26512092
5.
Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.
Proc Natl Acad Sci U S A
; 111(5): 1939-44, 2014 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24385585
6.
Atomic-level functional model of dengue virus Envelope protein infectivity.
Proc Natl Acad Sci U S A
; 110(46): 18662-7, 2013 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24158478
7.
Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.
J Virol
; 88(24): 14364-79, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25275138
8.
Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop.
J Virol
; 87(1): 52-66, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23077306
9.
Asymmetric deactivation of HIV-1 gp41 following fusion inhibitor binding.
PLoS Pathog
; 5(11): e1000674, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19956769
10.
New Insights into Immune-Based Diagnosis, Therapy and Prophylaxis for Infectious Diseases 2020.
J Immunol Res
; 2021: 9767464, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35005035
11.
Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response.
Genome Med
; 8(1): 23, 2016 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26917418
12.
Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.
Cell Host Microbe
; 18(1): 86-95, 2015 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26159721
13.
HCV E2 core structures and mAbs: something is still missing.
Drug Discov Today
; 19(12): 1964-70, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25172800
14.
The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein.
mBio
; 4(6): e00873-13, 2013 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24255124
15.
A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease.
PLoS Negl Trop Dis
; 7(9): e2423, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24069479
16.
New Insights for Immune-Based Diagnosis and Therapy for Infectious Diseases.
J Immunol Res
; 2017: 3104719, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28758132